Search Results - "Samizadeh, Mahta"

Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Tear Production in a Mouse Model of Sjögren's Syndrome by Kublin, Claire L., Hamm-Alvarez, Sarah F., Zoukhri, Driss, Sendra, Victor G., Meng, Zhen, Janga, Srikanth R., Armaos, Helene L., Hawley, Dillon R., Edman, Maria C., Samizadeh, Mahta, Aluri, Hema S., Hamrah, Pedram

“…The purpose of the present study was to test the potential of mouse bone marrow-derived mesenchymal stem cells (BD-MSCs) in improving tear production in a…”
Get full text

Abstract 299: Synergistic activity of mebendazole and chemotherapeutic agents for rare cancers by Samizadeh, Mahta, Chakrabarti, Debashree, Zhu, Yuhan, Treuting, Robert Louis, Kaplan, Johanne, Siders, William, Barber, Jamie D.

“…Depending upon the definition used, as many as half of all cancers diagnosed are considered rare cancers, and most rare cancer patients would greatly benefit…”
Get full text

Abstract 4801: Potential of mebendazole as an anti-tumor agent for adenoid cystic carcinoma and other rare cancers by Barber, Jamie Dempsey, Samizadeh, Mahta, Jia, Nannan, Siders, William, Kaplan, Johanne

“…Adenoid Cystic Carcinoma (ACC) is a rare adenocarcinoma arising most commonly in the major and minor salivary glands of the head and neck. Despite a deepening…”
Get full text

Abstract 7647: Identification of transcriptional plasticity biomarkers for patient stratification by Goldstein, Jeremy, Gavazzi, Christina, Grushko, Mikhail, Samizadeh, Mahta, ElSeht, Zakary, Arline, Katherine

“…Biomarker signatures associated with disease progression are important tools for the management of patient care. However, such signatures are frequently…”
Get full text

Abstract 4278: Transcriptome-driven combination design: A computational approach by Gavazzi, Christina, Grushko, Mikhail G., Goldstein, Jeremy M., Samizadeh, Mahta, ElSeht, Zakary Y., Arline, Katherine

“…While rational drug combination design seeks to improve patient outcomes by leveraging biological synergy, outcomes from combination trials often fail. Only…”
Get full text

Role of Matrix Metalloproteinases 2 and 9 in Lacrimal Gland Disease in Animal Models of Sjögren's Syndrome by Aluri, Hema S, Kublin, Claire L, Thotakura, Suharika, Armaos, Helene, Samizadeh, Mahta, Hawley, Dillon, Thomas, William M, Leavis, Paul, Makarenkova, Helen P, Zoukhri, Driss

“…Chronic inflammation of the lacrimal gland results in changes in the composition of the extracellular matrix (ECM), which is believed to compromise tissue…”
Get full text

Anti-HIV drug conjugates for enhanced mucosal pre-exposure prophylaxis by Samizadeh, Mahta

“…To combat HIV pandemic, targeting HIV mucosal transmission appears to be more effective than targeting later stages of the infection owing to the viral…”
Get full text

Colorectal delivery and retention of PEG-Amprenavir-Bac7 nanoconjugates—proof of concept for HIV mucosal pre-exposure prophylaxis by Samizadeh, Mahta, Zhang, Xiaoping, Gunaseelan, Simi, Nelson, Antoinette G., Palombo, Matthew S., Myers, Daniel R., Singh, Yashveer, Ganapathi, Usha, Szekely, Zoltan, Sinko, Patrick J.

“…Local delivery of anti-HIV drugs to the colorectal mucosa, a major site of HIV replication, and their retention within mucosal tissue would allow for a…”
Get full text

Multimeric peptide-based PEG nanocarriers with programmable elimination properties by Gunaseelan, Simi, Pooyan, Shahriar, Chen, Peiming, Samizadeh, Mahta, Palombo, Matthew S, Stein, Stanley, Zhang, Xiaoping, Sinko, Patrick J

“…Abstract In the current study, the design, synthetic feasibility and biochemical characterization of biodegradable peptidic PEG-based nanocarriers are…”
Get full text